Clinical Scorecard: Prevalence of Gender-Affirming Medical Care, Satisfaction With Treatment Decisions, and Unmet Need Among Transgender Adults
At a Glance
Category
Detail
Condition
Clinical topic addressed by the source article: Prevalence of Gender-Affirming Medical Care, Satisfaction With Treatment Decisions, and Unmet Need Among Transgender Adults
Key Mechanisms
Mechanisms or clinical associations described in the source article.
Target Population
72 survey respondents aged 16 years or older in Sweden who reported current or past experience as a transgender individual.
Care Setting
Swedish national population-based cohort survey linked with registry data.
Key Highlights
Any gender-affirming surgery was reported by 23 participants (32.4%); ongoing hormone treatment was reported by 30 (42.3%).
Among participants assigned female at birth, masculinizing chest surgery was reported by 43.5%; among those assigned male at birth, hair removal was reported by 32.0%.
All participants who had received gender-affirming hormones, surgery, and/or procedures reported satisfaction with their treatment decisions.
Many participants who had not received particular treatments reported wanting them, including chest surgery among participants assigned female at birth and hair removal, orchiectomy, and voice therapy among participants assigned male at birth.
The study had substantial attrition and a small sample. The authors state that the findings should not be generalized to children.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Interpret prevalence estimates in light of substantial attrition and the small sample size.
The authors state that the findings should not be generalized to children.
Patient & Prescribing Data
The analysis included 72 Swedish survey respondents aged 16 years or older who currently or formerly identified as transgender; six reported a former identity, and none of those six had received gender-affirming treatment.
Among respondents, 30 (42.3%) were currently using gender-affirming hormones, 2 (2.8%) had used hormones previously, and 39 (54.9%) had never used them. Twenty-three (32.4%) reported any gender-affirming surgery. All participants who had received hormones, surgery, and/or procedures reported satisfaction with their treatment decision.
Optical analysis of resection-margin tissue identified tumor infiltration as the strongest contributor to predictions of where glioblastoma later recurred.
